AI주식인사이트AI Stock Insight
C

얼라인드

238120KOSDAQ사진장비 및 광학기기 제조업

47.5 / 100

Reference Date: 2026-07-24

Financial Score16.0 / 40
News Sentiment12.5 / 25
Momentum9.0 / 20
Disclosure10.0 / 15
AI Analysis: PER is significantly undervalued vs. peers but the high debt ratio poses financial risk. Slightly up 1.8% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Aligned is a technology venture company specializing in life science research and diagnostics, offering advanced products such as automated cell counting systems, tissue clearing and imaging systems, and digital cell imaging systems. Leveraging convergent technologies, the company has established a competitive edge globally with its X-CLARITY™ and CELENA® series, gaining trust from researchers. The growing life science tools market, driven by increased investment in healthcare and biotech, is expected to sustain the company's growth.

Number of Employees

66people

Average Salary

56.1M KRW

Score Calculation Basis

Detailed Financial Score

PER
14.95Industry Average 15.375.0Point

In line with industry avg

PBR
1.18Industry Average 1.254.0Point

In line with industry avg

ROE
8.01Industry Average -11.913.5Point

Well below industry avg

Debt Ratio
43.44Industry Average 18.090.0Point

2.4x industry avg (risky)

Trend 2023~20253.5 / 10 points
Revenue Growth Rate
1.0 / 3

Avg ▲2.6% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼14.4% (2-year basis)

ROE Trend
2.5 / 4

Avg ROE 10.4% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (5%, downtrend)

Current 3,080Won52-week high 6,05052-week low 2,900
1-month return3.0Point

1m 1.82% (flat)

Volume trend5.0Point

Volume increasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0
  • Neutral[기재정정]주요사항보고서(자기주식처분결정)2026-06-30
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-26